Research study Program year 2024 Source: CMS Open Payments

A Phase 1b Multi-cohort Study of the Combination of Pembrolizumab MK-3475 plus Binimetinib alone or the Combination of Pembrolizumab plus Chemotherapy with or without Binimetinib in Participants with Metastatic Colorectal Cancer KEYNOTE-651

Research payments

$3,270,756

167 payments

Through program year 2024, $3,270,756 in research payments was reported against A Phase 1b Multi-cohort Study of the Combination of Pembrolizumab MK-3475 plus Binimetinib alone or the Combination of Pembrolizumab plus Chemotherapy with or without Binimetinib in Participants with Metastatic Colorectal Cancer KEYNOTE-651, across 167 payments, paid by Merck Sharp & Dohme Corporation.

Paid by
Merck Sharp & Dohme Corporation
ClinicalTrials.gov
No trial number was reported for this study

By program year

5 rows
Year Kind Amount Payments
2024 Research $39,033 14
2023 Research $138,151 15
2022 Research $622,247 33
2021 Research $1,783,385 23
2020 Research $687,939 82

Breakdown

Who paid Research payments · program years 2020–2024
  1. Merck Sharp & Dohme Corporation $3,270,756 167 payments
Who received the money Research payments · program years 2020–2024
  1. Moffitt Cancer Center Teaching hospital · FL $1,217,255 64 payments
  2. University of Chicago Organisation paid for research $644,471 21 payments
  3. University Of Washington Med Ctr Teaching hospital · WA $370,612 8 payments
  4. Baylor Scott and White Organisation paid for research $274,498 26 payments
  5. Yale Cancer Center Organisation paid for research $207,082 9 payments
  6. Scott And White Memorial Hospital Teaching hospital · TX $151,638 3 payments
  7. Anschutz Medical Campus, Anschutz Cancer Pavilion Organisation paid for research $122,845 6 payments
  8. Northwest Medical Specialties, Pllc Organisation paid for research $106,675 6 payments
  9. Rutgers Cancer Institute Of New Jersey Organisation paid for research $88,804 11 payments
  10. City Of Hope National Medical Ctr Teaching hospital · CA $46,965 8 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record